Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].

Literature DB >> 25533324

[Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].

E Dahl¹, A Jung, J Fassunke, M Hummel, R Penzel, W Dietmaier, S Laßmann.

Abstract

Entities: Disease

Mesh：

Substances：
DNA, Neoplasm

Year: 2015 PMID： 25533324 DOI： 10.1007/s00292-014-2069-x

Source DB: PubMed Journal: Pathologe ISSN： 0172-8113 Impact factor: 1.011

× No keyword cloud information.

33 in total

1. Information from CTC measurements for metastatic breast cancer prognosis-we should do more than selecting an "optimal cut point".

Authors: T Fehm; W Sauerbrei
Journal: Breast Cancer Res Treat Date: 2010-02-04 Impact factor: 4.872

2. Selection and adaptation during metastatic cancer progression.

Authors: Christoph A Klein
Journal: Nature Date: 2013-09-19 Impact factor: 49.962

3. Detection of circulating tumor DNA in early- and late-stage human malignancies.

Authors: Chetan Bettegowda; Mark Sausen; Rebecca J Leary; Isaac Kinde; Yuxuan Wang; Nishant Agrawal; Bjarne R Bartlett; Hao Wang; Brandon Luber; Rhoda M Alani; Emmanuel S Antonarakis; Nilofer S Azad; Alberto Bardelli; Henry Brem; John L Cameron; Clarence C Lee; Leslie A Fecher; Gary L Gallia; Peter Gibbs; Dung Le; Robert L Giuntoli; Michael Goggins; Michael D Hogarty; Matthias Holdhoff; Seung-Mo Hong; Yuchen Jiao; Hartmut H Juhl; Jenny J Kim; Giulia Siravegna; Daniel A Laheru; Calogero Lauricella; Michael Lim; Evan J Lipson; Suely Kazue Nagahashi Marie; George J Netto; Kelly S Oliner; Alessandro Olivi; Louise Olsson; Gregory J Riggins; Andrea Sartore-Bianchi; Kerstin Schmidt; le-Ming Shih; Sueli Mieko Oba-Shinjo; Salvatore Siena; Dan Theodorescu; Jeanne Tie; Timothy T Harkins; Silvio Veronese; Tian-Li Wang; Jon D Weingart; Christopher L Wolfgang; Laura D Wood; Dongmei Xing; Ralph H Hruban; Jian Wu; Peter J Allen; C Max Schmidt; Michael A Choti; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Luis A Diaz
Journal: Sci Transl Med Date: 2014-02-19 Impact factor: 17.956

4. Circulating mutant DNA to assess tumor dynamics.

Authors: Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal: Nat Med Date: 2007-07-31 Impact factor: 53.440

5. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

Authors: Steven J Cohen; Cornelis J A Punt; Nicholas Iannotti; Bruce H Saidman; Kert D Sabbath; Nashat Y Gabrail; Joel Picus; Michael Morse; Edith Mitchell; M Craig Miller; Gerald V Doyle; Henk Tissing; Leon W M M Terstappen; Neal J Meropol
Journal: J Clin Oncol Date: 2008-07-01 Impact factor: 44.544

Review 6. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.

Authors: Nikolas H Stoecklein; Christoph A Klein
Journal: Int J Cancer Date: 2010-02-01 Impact factor: 7.396

7. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer.

Authors: Johann S de Bono; Howard I Scher; R Bruce Montgomery; Christopher Parker; M Craig Miller; Henk Tissing; Gerald V Doyle; Leon W W M Terstappen; Kenneth J Pienta; Derek Raghavan
Journal: Clin Cancer Res Date: 2008-10-01 Impact factor: 12.531

8. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing.

Authors: Ellen Heitzer; Martina Auer; Christin Gasch; Martin Pichler; Peter Ulz; Eva Maria Hoffmann; Sigurd Lax; Julie Waldispuehl-Geigl; Oliver Mauermann; Carolin Lackner; Gerald Höfler; Florian Eisner; Heinz Sill; Hellmut Samonigg; Klaus Pantel; Sabine Riethdorf; Thomas Bauernhofer; Jochen B Geigl; Michael R Speicher
Journal: Cancer Res Date: 2013-03-07 Impact factor: 12.701

Review 9. Considerations in the development of circulating tumor cell technology for clinical use.

Authors: David R Parkinson; Nicholas Dracopoli; Brenda Gumbs Petty; Carolyn Compton; Massimo Cristofanilli; Albert Deisseroth; Daniel F Hayes; Gordon Kapke; Prasanna Kumar; Jerry Sh Lee; Minetta C Liu; Robert McCormack; Stanislaw Mikulski; Larry Nagahara; Klaus Pantel; Sonia Pearson-White; Elizabeth A Punnoose; Lori T Roadcap; Andrew E Schade; Howard I Scher; Caroline C Sigman; Gary J Kelloff
Journal: J Transl Med Date: 2012-07-02 Impact factor: 5.531